-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Az3PgRTKEITOg6FH1Srepokl9EujiyjTENy6lU1qb+G7FZY27tyIhczz6U/cgXkN pTQKIR4TFrio5VmDf3jLyw== 0000950135-04-000731.txt : 20040213 0000950135-04-000731.hdr.sgml : 20040213 20040213144341 ACCESSION NUMBER: 0000950135-04-000731 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040213 GROUP MEMBERS: ABINGWORTH BIOVENTURES III A LP GROUP MEMBERS: ABINGWORTH BIOVENTURES III B LP GROUP MEMBERS: ABINGWORTH BIOVENTURES III C LP GROUP MEMBERS: ABINGWORTH BIOVENTURES III EXECUTIVES LP SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: 3 DIMENSIONAL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000914201 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232716487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-59449 FILM NUMBER: 04597832 BUSINESS ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 104 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 6104588959 MAIL ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 104 CITY: EXTON STATE: PA ZIP: 19341 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ABINGWORTH BIOVENTURES SICAV CENTRAL INDEX KEY: 0000895906 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 231 VAL DES BONS MALADES L-2121 CITY: LUXEMBERG-KIRCHBERG STATE: N4 BUSINESS PHONE: 3524389891 MAIL ADDRESS: STREET 1: 231 VAL DES BONS MALADES STREET 2: BOITE POSTALE 566 L2015 CITY: LUXEMBOURG STATE: N4 SC 13G/A 1 b49503absc13gza.txt 3 DIMENSIONAL PHARMACEUTICALS ----------------------------- OMB APPROVAL ----------------------------- OMB Number: 3235-0145 Expires: December 31, 2005 Estimated average burden hours per response . . . 14.9 ----------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 3)* 3-Dimensional Pharmaceuticals - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.001 par value per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 88554W104 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2003 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 12 pages - ------------------- ------------------ CUSIP NO. 88554W104 13G PAGE 2 OF 12 PAGES - ------------------- ------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Abingworth Bioventures SICAV, in liquidation - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Luxembourg - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER -0- NUMBER OF ---------------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY -0- EACH ---------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH -0- ---------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -0- - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 -0- - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO - -------------------------------------------------------------------------------- Page 2 of 12 pages - ------------------- ------------------ CUSIP NO. 88554W104 13G PAGE 3 OF 12 PAGES - ------------------- ------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Abingworth Bioventures III A L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION England - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER -0- NUMBER OF ---------------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY -0- EACH ---------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH -0- ---------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -0- - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 -0- - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 3 of 12 pages - ------------------- ------------------ CUSIP NO. 88554W104 13G PAGE 4 OF 12 PAGES - ------------------- ------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Abingworth Bioventures III B L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION England - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER -0- NUMBER OF ---------------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY -0- EACH ---------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH -0- ---------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -0- - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 -0- - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 4 of 12 pages - ------------------- ------------------ CUSIP NO. 88554W104 13G PAGE 5 OF 12 PAGES - ------------------- ------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Abingworth Bioventures III C L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION England - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER -0- NUMBER OF ---------------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY -0- EACH ---------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH -0- ---------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -0- - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 -0- - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 5 of 12 pages - ------------------- ------------------ CUSIP NO. 88554W104 13G PAGE 6 OF 12 PAGES - ------------------- ------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Abingworth Executives III L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER -0- NUMBER OF ---------------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY -0- EACH ---------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH -0- ---------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -0- - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 -0- - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- Page 6 of 12 pages - ------------------- ------------------ CUSIP NO. 88554W104 13G PAGE 7 OF 12 PAGES - ------------------- ------------------ Item 1(a). Name of Issuer: 3-Dimensional Pharmaceuticals, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 1020 Stony Hill Road, Suite 300, Yardley, Pennsylvania 19067 Item 2(a). Name of Person Filing: Abingworth Bioventures SICAV, in liquidation ("Abingworth SICAV"), Abingworth Bioventures III A L.P. ("Abingworth III A"), Abingworth Bioventures III B L.P. ("Abingworth III B"), Abingworth Bioventures III C L.P. ("Abingworth III C"), and Abingworth Bioventures III Executives L.P. ("Abingworth III Executives"). See attached Exhibit 1, which is a copy of their agreement in writing to file this statement on behalf of each of them. Item 2(b). Address of Principal Business Office or, if None, Residence: The business address for Abingworth SICAV is 231 Val des Bons Malades, L-2121, Luxembourg-Kirchberg, Luxembourg. The business address for Abingworth III A, Abingworth III B, Abingworth III C and Abingworth III Executives is c/o Abingworth Management Limited, Princes House, 38 Jermyn Street, London, England SW1Y 6DN. Item 2(c). Citizenship: Abingworth SICAV is a corporation organized under the laws of Luxembourg. Abingworth III A, Abingworth III B and Abingworth III C are limited partnerships organized under the laws of England. Abingworth III Executives is a limited partnership organized under the laws of Delaware. Item 2(d). Title of Class of Securities: Common Stock, $.001 par value per share. Item 2(e). CUSIP Number: 88554W104 Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) [ ] Broker or Dealer registered under Section 15 of the Securities Exchange Act of 1934 (the "Act"). (b) [ ] Bank as defined in Section 3(a)(6) of the Act. (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act. (d) [ ] Investment Company registered under Section 8 of the Investment Company Act. (e) [ ] Investment Advisor registered under Section 203 of the Investment Advisers Act of 1940. (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see 13d-1(b)(1)(ii)(F). Page 7 of 12 pages - ------------------- ------------------ CUSIP NO. 88554W104 13G PAGE 8 OF 12 PAGES - ------------------- ------------------ (g) [ ] Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G); see Item 7. (h) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(H). Not applicable. Item 4. Ownership. Not applicable. Item 5. Ownership of Five Percent or Less of a Class. Each Reporting Person has ceased to beneficially own more than 5% of the outstanding Common Stock of the Issuer. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Page 8 of 12 pages - ------------------- ------------------ CUSIP NO. 88554W104 13G PAGE 9 OF 12 PAGES - ------------------- ------------------ SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 12, 2004 ABINGWORTH BIOVENTURES SICAV, IN LIQUIDATION By: /s/ Genevieve BLAUEN ------------------------- Name: Genevieve BLAUEN Title: Company Secretary By: /s/ Gerard Muller ------------------------- Name: Gerard Muller Title: Mandatory ABINGWORTH BIOVENTURES III A L.P. By: Abingworth Management Limited, its Manager By: /s/ James Abell ------------------------- Name: James Abell Title: Executive Director ABINGWORTH BIOVENTURES III B L.P. By: Abingworth Management Limited, its Manager By: /s/ James Abell ------------------------- Name: James Abell Title: Executive Director Page 9 of 12 pages - ------------------- ------------------- CUSIP NO. 88554W104 13G PAGE 10 OF 12 PAGES - ------------------- ------------------- ABINGWORTH BIOVENTURES III C L.P. By: Abingworth Management Limited, its Manager By: /s/ James Abell ------------------------- Name: James Abell Title:Executive Director ABINGWORTH BIOVENTURES III EXECUTIVES L.P. By: Abingworth Management Limited, its Manager By: /s/ James Abell ------------------------- Name: James Abell Title: Executive Director Page 10 of 12 pages - ------------------- ------------------- CUSIP NO. 88554W104 13G PAGE 11 OF 12 PAGES - ------------------- ------------------- AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13 need be filed with respect to the ownership by each of the undersigned of shares of stock of 3-Dimensional Pharmaceuticals, Inc. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original. EXECUTED this 12th day of February, 2004. ABINGWORTH BIOVENTURES SICAV, IN LIQUIDATION By: /s/ Genevieve BLAUEN ------------------------- Name: Genevieve BLAUEN Title: Company Secretary By: /s/ Gerard Muller ------------------------- Name: Gerard Muller Title: Mandatory ABINGWORTH BIOVENTURES III A L.P. By: Abingworth Management Limited, its Manager By: /s/ James Abell ------------------------- Name: James Abell Title: Executive Director ABINGWORTH BIOVENTURES III B L.P. By: Abingworth Management Limited, its Manager By: /s/ James Abell ------------------------- Name: James Abell Title: Executive Director Page 11 of 12 pages - ------------------- ------------------- CUSIP NO. 88554W104 13G PAGE 12 OF 12 PAGES - ------------------- ------------------- ABINGWORTH BIOVENTURES III C L.P. By: Abingworth Management Limited, its Manager By: /s/ James Abell ------------------------ Name: James Abell Title: Executive Director ABINGWORTH BIOVENTURES III EXECUTIVES L.P. By: Abingworth Management Limited, its Manager By:/s/ James Abell ------------------------ Name: James Abell Title: Executive Director Page 12 of 12 pages -----END PRIVACY-ENHANCED MESSAGE-----